Literature DB >> 27600562

Melanoma in situ (MIS) in a patient with atypical mole syndrome (AMS): with aggressiveness to success?

G Tchernev1,2, A A Chokoeva3,4, T Lotti5,6, S Philipov7.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27600562     DOI: 10.1007/s10354-016-0503-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


× No keyword cloud information.
  6 in total

Review 1.  The "dysplastic" nevus.

Authors:  Robert J Friedman; Michele J Farber; Melanie A Warycha; Nicole Papathasis; Michael K Miller; Edward R Heilman
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

2.  Surgical excision margins for melanoma in situ.

Authors:  S Akhtar; W Bhat; A Magdum; P R W Stanley
Journal:  J Plast Reconstr Aesthet Surg       Date:  2013-12-12       Impact factor: 2.740

3.  Multiple primary cutaneous melanomas in patients with FAMMM syndrome and sporadic atypical mole syndrome (AMS): what's worse?

Authors:  Georgi Tchernev; Julian Ananiev; José-Carlos Cardoso; Anastasiya Atanasova Chokoeva; Stanislav Philipov; Plamen Kolev Penev; Torello Lotti; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-08-06

4.  Meyerson Phenomenon as a Component of Melanoma in situ.

Authors:  Engin Sezer; Emel Özturk Durmaz; Emel Çetin; Sedef Şahin
Journal:  Acta Dermatovenerol Croat       Date:  2016-04       Impact factor: 1.256

Review 5.  Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article.

Authors:  Juliana Hypólito Silva; B C de Sá; Alexandre Leon Ribeiro de Avila; Gilles Landman; João Pedreira Duprat Neto
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.

Authors:  V Bataille; J A Bishop; P Sasieni; A J Swerdlow; E Pinney; K Griffiths; J Cuzick
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.